BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
39 hedge funds and large institutions have $216M invested in BELLUS Health Inc. in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
27% more capital invested
Capital invested by funds: $170M → $216M (+$46M)
3% less funds holding
Funds holding: 40 → 39 (-1)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$6.22M |
| 2 |
RI
RTW Investments
New York
|
+$4.53M |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$3.34M |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$836K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$677K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
-$2.91M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.18M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$1.12M |
| 4 |
Goldman Sachs
New York
|
-$683K |
| 5 |
Morgan Stanley
New York
|
-$377K |
BLU Hedge Fund Activity: Q4 2019 in Review
39 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2019, worth a combined $216M — up 27% from $170M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new BLU positions and 6 closed out — a net gain of 4 holders — while 12 added to existing stakes and 9 trimmed.
The largest buyer was Polar Capital, adding an estimated $6.22M. The largest seller was First Manhattan, cutting an estimated $2.91M.
- 39 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2019, down from 40 in Q3 2019.
- Funds reported $216M of BELLUS Health Inc. stock for Q4 2019, up 27% quarter-over-quarter.
- 10 funds opened new BELLUS Health Inc. positions in Q4 2019 and 6 closed out, a net change of +4 holders.
- The largest BELLUS Health Inc. buyer in Q4 2019 was Polar Capital, an estimated $6.22M added.
- The largest BELLUS Health Inc. seller in Q4 2019 was First Manhattan, an estimated $2.91M sold.
Based on aggregated 13F filings for Q4 2019.